The study present a suite of methods to accurately profile, image, and quantify cell-surface RNAs while preserving plasma-membrane integrity.
Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at Increased Dose LevelsPatients are Now Be ...
This advisory highlights more than 100 poster abstracts that will be presented at ASH 2025 involving researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback